Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Cell Culture Media, Supplements, and Reagents
  4. Cell Culture Media
  5. Cell Target Type Cell Culture Media
  6. Hybridoma Myeloma Cell Culture Media
  7. SH3080001

Cytiva HyClone™ CDM4MAb Powdered Cell Culture Media

Catalog No. SH3080001 Shop All Cytiva Products
Change view
Click to view available options
Quantity:
5 L
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
SH3080001 5 L
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. SH3080001 Supplier Cytiva Supplier No. SH30800.01
Only null left
Add to Cart
Add to Cart

Description

ADCF medium for use with hybridoma and myeloma cell lines.

HyClone CDM4MAb is a chemically defined and animal-derived component-free (ADCF) medium. This regulatory-friendly medium is designed to increase process yields for the manufacture of antibodies and antibody fragments for therapeutic use in a variety of engineered hybridoma and myeloma cell lines.

  • Animal-derived component-free.
  • Chemically defined formulation
  • Designed for high cell yield and monoclonal antibody (MAb) production.
  • Allows for direct or sequential adaptation
  • Manufactured from traceable components according to cGMP guidelines
TRUSTED_SUSTAINABILITY

Specifications

Form Powder
Sterility Non-sterile
Without Additives No Glutamine, No Poloxamer 188
Quantity 5 L
Content And Storage 2 to 8°C, away from light and moisture
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.